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abstract: Decidualization of endometrial stromal cells (ESCs) is critical for a successful pregnancy but the molecular mechanisms of the
process are poorly understood. In this study, we investigated whether the insulin-like growth factor (IGF) network is involved in this cellular
process. Expression kinetics of members of the IGF system was examined at both mRNA and protein levels during in-vitro decidualization of
cultured human ESCs. We found a signiﬁcant up-regulation of IGF-II as well as of IGF-I receptor and the A and B insulin receptor (InsR) isoforms.
In addition, levels of the key adaptor proteins insulin receptor substrate 1 (IRS-1) and IRS-2 increased, suggesting a potential involvement of the IGF
signalling pathway in the decidualization process. Expression of two IGF binding proteins, IGFBP-1 and IGFBP-4, which can inhibit IGF action, also
increased. In order to determine whether IGF signalling was activated during decidualization, the phosphorylation status of the receptors and the
adaptor proteins was estimated. Only IRS-2 was slightly phosphorylated in decidualized cells and was further activated by the addition of exogen-
ous IGF-II. These results suggest that the IGF signalling pathway could play a crucial role in the functions of decidualized endometrial cells.
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Introduction
Decidualization of endometrial stromal cells (ESCs) is crucial for a suc-
cessful placentation and for the maintenance of pregnancy. It has been
demonstrated that inadequate uterine decidualization could compro-
mise female fertility (Benson et al., 1996; Robb et al., 1998; Lim
et al., 1999; Karpovich et al., 2005) or promote trophoblast cell inva-
sion resulting in intramyometrial placentation (Gofﬁn et al., 2003b).
The decidualization process consists of morphological and functional
differentiation of ESCs occurring during the late secretory phase of the
menstrual cycle, with the process progressing if pregnancy arises (Fer-
enczy and Bergeron, 1991). Decidualization can be induced in-vitro in
ESCs by progesterone after estradiol priming or by different cAMP indu-
cers such as prostaglandin E2, relaxin and gonadotrophins (LH, FSH)
(Tang and Gurpide, 1993; Frank et al., 1994; Lane et al., 1994; Brar
et al., 1997). Decidualization is induced with maximal efﬁciency by a
combination of 8-bromo-cAMP (8-br-cAMP) and medroxyprogester-
one acetate (MPA) (Gellersen and Brosens, 2003).
Insulin-like growth factors I (IGF-I) and II (IGF-II) act as endocrine,
paracrine and autocrine factors and are implicated in various cellular
activities such as proliferation, survival and differentiation. Their
actions are mediated by type I IGF receptor (IGF-IR) and insulin recep-
tor (InsR), which are highly homologous members of the tyrosine kinase
receptor family (Ullrich et al., 1986). Both IGF-IR and InsR are
tetrameric receptors composed of two extracellular a-subunits con-
taining the ligand binding domain, and two b-subunits which contain
the tyrosine kinase domain. Human InsR exists in two isoforms, A
(InsR-A) and B (InsR-B), generated from the alternative splicing of
exon 11, coding for the C-terminus of the a-subunit. The expression
of both isoforms is tightly regulated in a tissue-speciﬁc manner
(Moller et al., 1989; Mosthaf et al., 1990), likely reﬂecting distinct func-
tions. Moreover, it has been shown that InsR-A, but not InsR-B, binds to
IGF-II with a high afﬁnity, leading to increased mitogenic effects (Frasca
et al., 1999). Besides the classical receptors, hybrid IGF-I/Ins receptors
are present in mammalian tissues (Bailyes et al., 1997; Federici et al.,
1997). Functional studies have shown that hybrid receptors behave in
a manner similar to IGF-IR since they bind to IGF-I with a higher afﬁnity
than to insulin (Soos et al., 1993; Seely et al., 1995). Upon ligand binding,
the activated receptors recruit and phosphorylate scaffold proteins,
such as insulin receptor substrate 1 (IRS-1) and IRS-2, leading to the
activation of several intracellular signalling pathways including the
phosphatidylinositol-3 kinase (PI3K) and the mitogen-activated
protein kinase (MAPK) pathways (Siddle et al., 2001; White, 2002).
The type II IGF receptor (IGF-IIR) binds almost exclusively IGF-II and
is considered as a scavenger receptor for IGF-II. It is unclear whether
the receptor is able to initiate a signalling cascade.
The IGF network also includes six high-afﬁnity IGF binding proteins
(IGFBPs) regulating the interaction of IGFs with their receptors. IGFBP
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modulation of IGF action is complex, precluding the understanding of
the consequences of different IGFBP levels on IGF functions (Firth and
Baxter, 2002). Due to their high afﬁnity for IGFs, IGFBPs are able to
prevent the binding of the ligands to their receptors. Post-translational
modiﬁcations of some IGFBPs, as well as interaction with extracellular
matrix components, affect their afﬁnity for IGFs and therefore modu-
late IGF actions. In particular, proteolysis represents a major process
in the regulation of IGF bioavailability. IGFBP-2 to -5 are proteolysis
targets. IGFBP-3 and -5 proteolytic fragments conserve signiﬁcant
residual afﬁnity for IGFs but IGFBP-2 and IGFBP-4 fragments have a
drastically reduced IGF binding capacity (Jones and Clemmons, 1995).
Several observations have emphasized a potential role for the IGF
network in ESC differentiation. IGF network expression is modulated in
the endometrium and decidua during the normal menstrual cycle,
under the inﬂuence of steroid hormones (Nayak and Giudice, 2003).
Moreover, several microarray analyses have shown regulation of various
members of the IGF network in ESC cultures which have been induced
to differentiate (Brar et al., 2001; Tierney et al., 2003; Giudice, 2004).
In this study, we describe the expression of members of the IGF
network during in-vitro differentiation of the stromal cells induced by
the combination of cAMP and MPA. We provide detailed kinetics of
the expression of the ligands (IGF-I and IGF–II), the IGF binding pro-
teins (IGFBP-1 to -6), the receptors (InsR, IGF-IR and IGF-IIR) and the
key adaptor proteins (IRS-1 and IRS-2). We found that decidualization
was accompanied by an increase in IGF-II, IGFBP-1 and IGFBP-4 and
by a decrease in IGFBP-5. Concerning the receptors, the expression
of both InsR isoforms and of IGF-IR was up-regulated by the decidua-
lizing treatment. Expression levels of IRS-1 and IRS-2 increased equally.
To investigate whether the IGF signalling pathway was activated during
ESC differentiation, we also examined phosphorylation of the recep-
tors and the adaptor proteins in decidualized cells with or without
the addition of exogenous IGF peptides.
Materials and Methods
Tissue acquisition
Endometrial biopsies were obtained from premenopausal, cycling and not
hormonally treated women (age range: 31–42 years). The patients were
examined for benign reasons with the authorization of the local ethical
committee and had given their written informed consent. A portion of
each endometrial specimen was ﬁxed in formalin for histological dating
according to the criteria of Noyes et al. (1975).
Isolation and culture of ESCs
Normal proliferative and early secretory endometrial biopsies (between
days 6 and 16 of the menstrual cycle) were collected in HBSS containing
1% penicillin-streptomycin (Cambrex Bio Science, Baltimore, MD, USA).
ESCs were isolated according to the method of Brosens et al. (1999)
with minor modiﬁcations. Brieﬂy, endometrial tissue was ﬁnely minced
and enzymatically digested with 0.2% collagenase (Sigma, St Louis, MO,
USA) and 100 IU/ml deoxyribonuclease type 1 (Roche Molecular Bio-
chemicals, Mannheim, Germany) for 45 min at 378C. After centrifugation
at 1000g for 5 min, the pellets were suspended in DMEM/F12 (Gibco
BRL/Invitrogen, Carlsbad, CA, USA) containing 10% charcoal-stripped
FBS (Cambrex Bio Science), 1% penicillin–streptomycin and 0.25 mg/ml
fungizone (Gibco BRL/Invitrogen). Cells were sedimented by gravitation
for 30 min to separate stromal cells from glands. The ESC fraction was
enriched by the more rapid adherence of stromal cells to the dish and
was further separated from contaminating epithelial cells by selective tryp-
sinization. After two passages, the purity of stromal cell cultures was
assessed by negative cytokeratin immunostaining (,5% of epithelial cells).
Cells from passage 2 were grown in 10% charcoal-stripped FBS DMEM/
F12 medium until they reached conﬂuence and were then switched to
medium containing 2% charcoal-treated FBS for 24 h. Decidualizing treat-
ment consisting of 1 mM MPA (Sigma) and 0.5 mM 8-br-cAMP (Sigma) was
applied for the indicated time periods. The culture medium was renewed
every 3 days. Differentiation was assessed by examination of cell mor-
phology under phase contrast microscopy at various times during the
treatment and by measuring the expression of decidualization-speciﬁc
marker genes, namely IGFBP-1 and prolactin (PRL).
RNA extraction and RT–PCR
Total RNA from ESC cultures was isolated using TriPure (Roche Molecular
Biochemicals) reagent according to the manufacturer’s instructions and
was treated with RNase-free DNase (Roche Molecular Biochemicals).
First-strand cDNA was synthesized from 250 ng total RNA using
random hexamers (Invitrogen) and AMV Reverse Transcriptase
(Promega, Madison, WI, USA) in a ﬁnal volume of 50 ml. For cDNA ampli-
ﬁcation, a 2 ml aliquot of reverse transcription product was ampliﬁed in a
volume of 25 ml, containing 0.5 mM MgCl2, 200 mM of each deoxynucleo-
tide, 0.2 mM of each primer and 2.5 IU Taq DNA polymerase
(Perkin-Elmer Life Sciences, Boston, MA, USA). After denaturation at
958C for 2 min, PCR ampliﬁcation cycles consisted of 30 s at 948C, 60
s at the annealing temperature and 90 s at 728C, followed by a ﬁnal 7
min extension at 728C. The sequences of the oligonucleotide primers
(Eurogentec, Seraing, Belgium) and their respective annealing temperature
used for PCR reactions are given in Table I. The PCR products were quan-
tiﬁed after electrophoresis on a 10% polyacrylamide gel and staining with
Gelstar (FMC Bioproducts, Rockland, ME, USA) using a Fluor-STM MultiI-
mager (Bio-Rad Laboratories, Hercules, CA, USA). Densitometric values
of each assay sample were normalized with 28S rRNA levels used as
the internal control.
Protein extraction and western blot analysis
Cells were scraped and homogenized in lysis buffer [50 mM Hepes (pH
7.5), 150 mM NaCl, 1.5 mM MgCl2, 1% Triton X-100, 1 mM EGTA,
10% glycerol, 1 mM Na3VO4, 10 mM Na4P2O7, 100 mM NaF, protease
inhibitor cocktail Complete Mini (Roche Molecular Biochemicals)]. The
protein concentration of the lysates was determined using Pierce BCA
Protein Assay Reagent kit (Pierce, Rockford, IL, USA). Samples of 30 mg
protein per lane were resolved on a reducing 10–12% sodium dodecyl sul-
phate–polyacrylamide gel electrophoresis (SDS–PAGE) and were electro-
blotted onto a PVDF membrane (Millipore, Bedford, MA, USA). The
membrane was blocked by soaking in Tween Tris buffer [0.1% Tween
20, 50 mM Tris (pH 8.0), 150 mM NaCl] containing 5% non-fat dried
milk for 1 h and was then incubated with diluted primary antibody for 2
h at room temperature. The primary antibodies used were rabbit polyclo-
nal antibodies for IGF-IR (dilution 1:1000; Santa Cruz Biotechnology, Santa
Cruz, CA, USA), InsR (dilution 1:1000; Santa Cruz Biotechnology), IRS-1
(dilution 1:1000; Santa Cruz Biotechnology), IRS-2 (dilution 1:500; Santa
Cruz Biotechnology) and pregnancy associated plasma protein-A
(PAPP-A)/pro-MBP complex (dilution 1:1000; DakoCytomation,
Glostrup, Denmark), mouse monoclonal antibodies for IGBP-4 (dilution
1:1000; Austral Biologicals, San Ramon, CA, USA) and IGFBP-5 (dilution
1:500; Santa Cruz Biotechnology), goat polyclonal antibodies for
IGFBP-1 (dilution 1:1000; Santa Cruz Biotechnology) and Ku70 (dilution
1:1000; Santa Cruz Biotechnology) which was used as the protein
loading control. Signals were detected after incubation with horseradish
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peroxidase-conjugated secondary antibody (dilution 1:2000; DakoCyto-
maton) by using the ECL Western blotting system (Amersham Bio-
sciences, Buckinghamshire, UK).
Preparation and analysis of conditioned
medium from cell culture
Conditioned medium (CM) was collected after 8 h, 1, 3, 6, 9 and 12 days
and was centrifuged at 12 000g for 10 min to remove debris. The har-
vested CM was concentrated 5-fold by lyophilization and stored at
2708C. IGF-II secreted into the CM was quantiﬁed by immunoradio-
metric assay (IRMA) (Diagnostic Systems Laboratories Inc., Webster,
TX, USA) according to the manufacturer’s instructions. The sensitivity
of the IGF-II assay was 0.13 ng/ml and the intra- and inter-assay coefﬁ-
cients of variation were 4.3–7.2 and 6.3–10.4%, respectively. Levels of
IGF-II for each sample at each time point were assayed in duplicate and
were normalized to the amount of total protein in each well. Levels of
secreted IGFBP-4, IGFBP-5 and PAPP-A were evaluated by
immunoblotting.
Immunoneutralization of PAPP-A protease
Conﬂuent ESC cultures were treated with cAMP and MPA or with ethanol
carrier solution as the control (see above), in the absence or presence of
polyclonal anti-PAPP-A/pro-MBP complex antibody (10 and 50 mg/ml)
and control rabbit IgG (50 mg/ml) for 24 h. Proteolysis of endogenous
IGFBP-4 in concentrated CM was analysed by western blot.
Phosphorylation of IGF-IR, InsR, IRS-1 and
IRS-2
Phosphorylation of IGF-IR, InsR, IRS-1 and IRS-2 was studied in ESCs
grown at conﬂuence in 6 cm tissue culture dishes and treated with
.............................................................................................................................................................................................
Table I Sequences of the oligonucleotides used in the PCR reactions
Primer Sequence (50 –30) Annealing temperature (8C) Reference
IGF-I Forward TGGATGCTCTTCAGTTCGTG 59
Reverse CTGACTTGGCAGGCTTGAG
IGF-II Forward CGTCGCAGCCGTGGCATCGTTGA 57
Reverse GCCCACGGGGTATCTGGGGAAGT
IGFBP-1 Forward AGACGACGGAGATAACTGAGGA 57
Reverse GCCTTGGCTAAACTCTCTACGA
IGFBP-2 Forward CGGAAGCCCCTCAAGTCG 57 (Yi et al., 2001)
Reverse GCCTCCTGCTGCTCATTG
IGFBP-3 Forward CTCTCCCAGGCTACACCA 57 (Yi et al., 2001)
Reverse GAAGTCTGGGTGCTGTGC
IGFBP-4 Forward AAATTCGAGACCGGAGCAC 59
Reverse AGCTTCACCCCCGTCTTC
IGFBP-5 Forward AAGAAGGACCGCAGAAAG 57 (Yi et al., 2001)
Reverse GGGGACGCATCACTCAAC
IGFBP-6 Forward AACCGCAGAGACCAACAGAG 55
Reverse TTGGGCACGTAGAGTGTTTG
InsR Forward TTCCGAGACCTCAGTTTC 55 (Wu et al., 2003)
Reverse TGTGACTTACAGATGGT
InsRexon11 Forward AACCAGAGTGAGTATGAGGAT 58 (Frasca et al., 1999)
Reverse CCGTTCCAGAGCGAAGTGCTT
IGF-IR Forward GTGTACGTTCCTGATGAGTGGGAG 65 (Roy et al., 1997)
Reverse GCCCCGTGTCATCAGTTCCATGAT
IGF-IIR Forward TCAACATCTGTGGAAGTGTG 57 (Ilvesmaki et al., 1993)
Reverse GAATAGAGAAGTGTCCGGATCGGAGTC
IRS-1 Forward CTGGACATCACAGCAGAATGA 59
Reverse CGCTTGGCACAATATAGAACG
IRS-2 Forward AGATCTGTCTGGCTTTATCACCAGGA 55 (Wu et al., 2003)
Reverse CCTAGCATGCTGAGGGTTATATCTGC
PRL Forward GGTGACCCTTCGAGACCTGTT 60 (Gofﬁn et al., 2003a)
Reverse GGAAGAAGTGTGGCAGCTGTT
28S Forward GTTCACCCACTAATAGGGAACGTGA 68 (Gofﬁn et al., 2003a)
Reverse GATTCTGACTTAGAGGCGTTCAGT
The primers where no reference is indicated were designed by using Primer3 program (Rozen and Skaletsky, 2000).
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cAMP and MPA or with ethanol for 6 days. Untreated and treated cells
were stimulated with or without either 500 ng/ml IGF-II (Sigma) or
Long R3 IGF-I (LR3 IGF-I) (GroPep Ltd., Adelaide, Australia) for 15 min,
immediately prior to protein extraction. Long R3 IGF-I is a recombinant
peptide that does not bind to IGFBPs. Cells were rinsed in ice-cold PBS
and were incubated in lysis buffer [50 mM Tris (pH 8.0), 150 mM
NaCl, 1% NP-40, 0.25% sodium-deoxycholate, 1 mM Na3VO4, 10 mM
Na4P2O7, 100 mM NaF, protease inhibitor cocktail Complete Mini
(Roche Molecular Biochemicals)] for 30 min on ice. Cell debris was
eliminated by centrifugation at 12 000g for 15 min. Samples containing
400 mg protein extract were precleared for 60 min at 48C with control
rabbit IgG (Santa Cruz Biotechnology) and protein-A sepharose
(Amersham Biosciences). After centrifugation, the supernatant was incu-
bated at 48C overnight with 2 mg of the adequate antibody or control
rabbit IgG and then for 1 h with 30 ml of protein-A sepharose. Immuno-
precipitates were washed three times and diluted in 2 Laemmli Buffer.
Samples were boiled for 5 min before loading onto 6–8% SDS–PAGE.
Western blots were performed as described earlier by using anti-
phosphotyrosine 4G10 antibody (anti-PY) (Upstate Biotechnology, Lake
Placid, NY, USA).
Data analysis
Three different endometrial biopsies were analysed for the RT–PCR and
western blot experiments. From each biopsy, duplicate cultures were per-
formed for all experiments. Concerning the RT–PCR quantiﬁcations, the
ratio of densitometric values in decidualized versus non-decidualized cells
was calculated at each time point. The t-test was performed on the ratio
data averaged from the three independent samples (Statistica 7.1, Stat-
soft). P , 0.05 was considered as statistically signiﬁcant.
Results
Induction of decidualization by cAMP and
MPA
The morphology of the ESCs was examined under phase contrast
microscopy at various times after treatment to conﬁrm in-vitro decid-
ualization. The untreated ESCs retained their ﬁbroblastic spindle-
shaped appearance throughout the culture periods. The morphology
of the ESCs exposed to 8-br-cAMP and MPA started to change
after 3 days of culture. ESCs acquired a phenotype characteristic of
decidualization with a polygonal morphology and a more abundant
cytoplasm. Stromal changes were complete after 6 days of treatment
(Fig. 1A). The second method for assessing the decidualization con-
sisted of the evaluation of the expression of decidualization markers.
PRL and IGFBP-1 mRNA levels were induced as soon as 8 h after
the beginning of treatment and reached their maximum at 3 days
(Fig. 1B). Moreover, IGFBP-1 protein was detected by immunoblotting
in cellular protein extracts and in CM of treated cells (Fig. 1C).
IGFBP-1 expression increased rapidly from 8 h up to 3 days and
then remained elevated, in agreement with mRNA results.
Kinetics of IGF ligand expression
Total RNA was extracted from cells cultured with or without MPA
and 8-br-cAMP for 8 h, 1, 3, 6 and 12 days. The expression of
IGF-I and -II mRNAs was analysed by semi-quantitative RT–PCR.
IGF-I was not signiﬁcantly regulated by cAMP and MPA (data not
shown). Signiﬁcant induction of IGF-II mRNA levels was observed
after 1 day and reached a maximum of 2.6-fold, after 3 days of
treatment (Fig. 2A and B; P , 0.05 at 1, 3, 6 and 12 days). A mod-
erate IGF-II mRNA increase was also observed in untreated cells
but the increase in IGF-II remained statistically higher in treated cells
up to 12 days of culture. IGF-II protein concentration was measured
by IRMA in CM, collected at different time points of treatment. Pro-
duction of IGF-II was signiﬁcantly higher in cells treated with
8-br-cAMP and MPA from 6 days onwards (Fig. 2C; P , 0.05 at 6,
9 and 12 days).
Kinetics of IGFBP expression
We compared the changes in IGFBP mRNA and protein levels in
treated and untreated ESCs. As already mentioned, IGFBP-1
Figure 1 Assessment of in-vitro decidualization of ESCs. Conﬂuent
cultures of ESCs were treated with 0.5 mM 8-br-cAMP and 1 mM
MPA or were cultured in control medium. The medium was
renewed every 3 days. (A) Morphological appearance of ESCs under
phase contrast microscopy after 6 days of culture. Cells treated with
cAMP and MPA exhibited morphological changes typical of decidual
cells with large polygonal form, while untreated cells retained a
ﬁbroblast-like spindle-shaped appearance (original magniﬁcation
40). (B) Induction of IGFBP-1 and PRL mRNA levels in ESCs
treated with cAMP and MPA. Total RNA was extracted after 0, 8 h,
1, 3, 6, 12 days of treatment from untreated cells (2) and from cells
treated with cAMP and MPA (þ). The expression of IGFBP-1 and
PRL genes was analysed by RT–PCR. One representative experiment
of three similar experiments is shown. (C) IGFBP-1 protein levels
measured by western blot. Immunoblotting of IGFBP-1 was performed
on protein extracts (PE) and on conditioned media (CM) from
untreated cells (2) and from cells treated with cAMP and MPA (þ).
Whole cell lysates were extracted after 0, 8 h, 1, 3, 6, 12 days of treat-
ment and conditioned media were collected after 8 h (for period 0–8
h), 1 (for period 0–1 day), 3 (for period 0–3 days), 6 (for period 3–6
days), 9 (for period 6–9 days) and 12 (for period 9–12 days) days of
culture. Experiments were repeated three times with similar results.
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expression was induced by cAMP and MPA treatment (Fig. 1B and C).
Among the ﬁve other IGFBPs, only the expression of IGFBP-4 and of
IGFBP-5 was signiﬁcantly altered by decidualizing treatment.
IGFBP-4 mRNA showed rapid and constant induction (Fig. 3A and
B; P , 0.05 at 8 h, 1, 3, 6 and 12 days). The evolution of this protein
level was followed both in cellular protein extracts and in CM of ESCs
treated or not for decidualization, as the protein being secreted. As
shown in Fig. 3C, cellular IGFBP-4 levels increased progressively start-
ing from 8 h of decidualizing stimulation. A parallel evolution of the full
length 32 kDa protein was observed in CM of treated cells. Moreover,
a strong 18 kDa signal was detected in CM from both treated and
untreated cells. This 18 kDa band could correspond to the proteolysis
product of IGFBP-4 which has been identiﬁed in diverse cultured cell
types.
In particular, the 18 kDa IGFBP-4 fragment has been described in
CM of ESCs. The protease responsible for the degradation was
identiﬁed as the PAPP-A (Giudice et al., 2002). This protease
belongs to the superfamily of zinc peptidases and circulates in preg-
nancy serum in complex with the precursor of major basic protein
(pro-MBP) (Boldt et al., 2001). To ﬁnd out whether PAPP-A was
responsible for IGFBP-4 proteolysis in CM from treated and untreated
ESCs, we ﬁrst investigated PAPP-A expression by immunoblotting with
an anti-PAPP-A/pro-MBP complex antibody (Fig. 3D). The expression
of the protease was increased by decidualizing treatment, as previously
observed (Giudice et al., 2002). Attribution of IGFBP-4 proteolysis to
PAPP-A was assessed by immunoneutralization experiments. Cells
were cultured for 24 h in the presence or absence of polyclonal
anti-PAPP-A antibody and CM were subjected to IGFBP-4 western
blot. As shown in Fig. 3E, addition of PAPP-A blocking antibody to
the culture medium dose-dependently inhibited the formation of 18
kDa IGFBP-4 fragments in both untreated and treated cells, indicating
that proteolysis of IGFBP-4 was due to PAPP-A.
Figure 2 Expression time course of IGF-II during decidualization. (A) IGF-II mRNA levels measured by RT–PCR in ESC cultures. Total RNA was
extracted from non-decidualized (ND) and decidualized (D) cells after 0, 8 h, 1, 3, 6 and 12 days of treatment. The presented results are from a single
representative experiment. The densitometric values obtained for IGF-II mRNA at each time point were referred to the densitometric value at time 0
h considered as being equal to 1. (B) Fold induction of IGF-II mRNA levels. Table shows the ratio of densitometric values at each time point in decid-
ualized versus non-decidualized cells. Data represent the mean and SD summarized from three independent experiments performed in duplicate.
Statistical signiﬁcance of the differences above value for time point 0 h was determined by the Student’s t-test (*P , 0.05). (C) Production of
IGF-II by cultured ESCs treated with cAMP and MPA. IGF-II concentration was determined by immunoradiometric assay in conditioned media of non-
decidualized (ND) and decidualized (D) cells collected after 8 h (for period 0–8 h), 1 (for period 0–1 day), 3 (for period 0–3 days), 6 (for period 3–6
days), 9 (for period 6–9 days) and 12 (for period 9–12 days) days of culture. Concentration of IGF-II in DMEM/F12 2% charcoal-treated FBS was
below the detection level. Each sample was assayed in duplicate and values were normalized to the total protein amount. Data represent the mean and
SD of three separate experiments (*P , 0.05).
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IGFBP-5 mRNA expression was progressively and strongly inhibited
in decidualized cells, becoming undetectable after 6 days of treatment
(Fig. 4A and B; P , 0.05 at 1, 3, 6 and 12 days). Immunoblots of
IGFBP-5 protein could not be reliably performed due to low levels
of expression in stromal cells.
Kinetics of IGF and InsR expression
The changes in IGF-IR and InsR mRNA levels in cAMP and MPA
treated cells compared with vehicle treated cells were evaluated by
RT–PCR. The results, presented in Fig. 5A, show that the treatment
stimulated IGF-IR and InsR expression. In contrast, IGF-IIR expression
was unchanged (data not shown). Both IGF-IR and InsR mRNAs
rapidly and gradually increased. The induction of IGF-IR mRNA
levels peaked at 1.5-fold after 6 days of treatment (Fig. 5B; P ,
0.05 at 8 h, 3, 6 and 12 days), whereas the induction of InsR
Figure 3 Expression time course of IGFBP-4 during decidualization
and involvement of the PAPP-A in the proteolysis of IGFBP-4.
(A) IGFBP-4 mRNA levels measured by RT–PCR in ESC cultures.
Total RNA was extracted from non-decidualized (ND) and decidua-
lized (D) cells after 0, 8 h, 1, 3, 6 and 12 days of treatment. The pre-
sented results are from a single representative experiment. The
densitometric values obtained for IGFBP-4 mRNA at each time point
were referred to the densitometric value at time 0 h considered as
being equal to 1. (B) Fold induction of IGFBP-4 mRNA levels. Table
shows the ratio of densitometric values at each time point in decidua-
lized versus non-decidualized cells. Data represent the mean and SD
summarized from three independent experiments performed in dupli-
cate. Statistical signiﬁcance of the differences above value for time point
0 h was determined by the Student’s t-test (*P , 0.05). (C) IGFBP-4
protein levels measured by western blot in ESC cultures. Immunoblot-
ting of IGFBP-4 was performed on protein extracts (PE) and on con-
ditioned media (CM) from untreated cells (2) and from cells treated
with cAMP and MPA (þ). Whole cell lysates were extracted after 0,
8 h, 1, 3, 6, 12 days of treatment and conditioned media were col-
lected after 8 h (for period 0–8 h), 1 (for period 0–1 day), 3 (for
period 0–3 days), 6 (for period 3–6 days), 9 (for period 6–9 days)
and 12 (for period 9–12 days) days of culture. Experiments were
repeated three times with similar results. (D) PAPP-A protein levels
measured by western blot. Protein extracts (PE) and conditioned
media (CM) from untreated cells (2) and from cells treated with
cAMP and MPA (þ) were analysed by western blot with polyclonal
anti-PAPP-A/pro-MBP antibody. Whole cell lysates were extracted
after 0, 8 h, 1, 3, 6, 12 days of treatment and conditioned media
were collected after 8 h (for period 0–8 h), 1 (for period 0–1 day),
3 (for period 0–3 days), 6 (for period 3–6 days), 9 (for period 6–9
days) and 12 (for period 9–12 days) days of culture. Three separate
experiments gave similar results. (E) Inhibition of the proteolysis of
IGFBP-4 by PAPP-A immunoneutralization in ESC cultures. ESCs
were decidualized with cAMP and MPA (D) or not (ND) in the
presence of antibody against PAPP-A/pro-MBP complex (10 or 50
mg/ml) or non-speciﬁc anti-rabbit IgG (50 mg/ml). Conditioned
media were collected after 24 h and were analysed by western blot
by using anti-IGFBP-4 antibody.
Figure 4 Expression time course of IGFBP-5 during decidualization.
(A) IGFBP-5 mRNA levels measured by RT–PCR in ESC cultures.
Total RNA was extracted from non-decidualized (ND) and decidua-
lized (D) cells after 0, 8 h, 1, 3, 6 and 12 days of treatment. The pre-
sented results are from a single representative experiment. The
densitometric values obtained for IGFBP-5 mRNA at each time point
were referred to the densitometric value at time 0 h considered as
being equal to 1. (B) Fold induction of IGFBP-5 mRNA levels. Table
shows the ratio of densitometric values at each time point in decidua-
lized versus non-decidualized cells. Data represent the mean and SD
summarized from three independent experiments performed in dupli-
cate. Statistical signiﬁcance of the differences above value for time point
0 h was determined by the Student’s t-test (*P , 0.05).
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mRNA levels peaked at 2-fold after 1 day of treatment (Fig. 5B; P ,
0.05 at 8 h, 1, 3, 6 and 12 days).
Next, we evaluated the modulation of IGF-IR and InsR protein levels
by using speciﬁc antibodies for western blotting. In comparison to
control cells, the levels of both receptors were slightly increased after
8 h of decidualizing treatment. A progressive increase in both receptor
levels was observed throughout treatment (Fig. 5C). Levels of InsR and
IGF-IR proteins also increased in control cell cultures, notably after 12
days of treatment, but the difference between decidualized and non-
decidualized cells remained obvious at each time point.
Two InsR mRNA isoforms have been previously described, InsR-A
and InsR-B, generated by the alternative splicing of exon 11 (Moller
et al., 1989; Mosthaf et al., 1990). We investigated the relative abun-
dance of both isoforms during decidualization, by RT–PCR using
primers ﬂanking exon 11. Results demonstrated that isoforms InsR-A
and -B were expressed in untreated ESCs with the predominant
expression of InsR-B (Fig. 6A). Both isoforms were affected by decidua-
lizing treatment. The level of InsR-A rose to 3.4-fold after 6 days of treat-
ment, while the InsR-B mRNA isoform level doubled after 1 day
but decreased thereafter (Fig. 6B; P , 0.05 at 1, 3, 6 and 12 days
for InsR-A and P , 0.05 at 8 h, 1 and 3 days for InsR-B). InsR-A
represented 33% of the InsR mRNA present at the moment of
treatment. Its relative percentage reached 51% after 3 days of treat-
ment, becoming the major isoform from this time point onwards
(Fig. 6C). This could lead to a signiﬁcant IGF-II-mediated cell
stimulation, since it has been shown that InsR-A binds IGF-II with high
afﬁnity (Frasca et al., 1999). In control cells, the relative proportion of
the isoforms did not vary signiﬁcantly.
Kinetics of IRS-1 and IRS-2
Levels of both IRS-1 and IRS-2 were signiﬁcantly enhanced by the
decidualizing treatment. IRS-1 mRNA increased rapidly, starting from
8 h of treatment, and peaked at 2.3-fold after 3 days of treatment
(Fig. 7A and B; P , 0.05 at 8 h, 1, 3 and 6 days). A signiﬁcant induction
of IRS-2 mRNA was observed after 1 day in decidualized cells and
reached a maximum of 2.1-fold after 3 days of treatment (Fig. 7A
and B; P , 0.05 at 1, 3 and 6 days). The changes in IRS-1 and
IRS-2 expression were conﬁrmed at protein level by western blot.
The speciﬁcity of the antibodies used to identify them was conﬁrmed
by the differential migration of the two proteins on SDS–PAGE, IRS-2
(180 kDa) migrating slower than IRS-1 (165 kDa). Both proteins
levels started to increase from 8 h of treatment onwards (Fig. 7C).
Concerning the IRS-2 immunoblot, we observed a diffuse signal in
Figure 5 Expression time course of IGF-IR and InsR during decidualization. (A) IGF-IR and InsR mRNA levels measured by RT–PCR in ESC cul-
tures. Total RNA was extracted from non-decidualized (ND) and decidualized (D) cells after 0, 8 h, 1, 3, 6 and 12 days of treatment. The presented
results are from a single representative experiment. The densitometric values obtained for IGF-IR and InsR mRNA at each time point were referred to
the densitometric value at time 0 h considered as being equal to 1. (B) Fold induction of IGF-IR and InsR mRNA levels. Table shows the ratio of
densitometric values at each time point in decidualized versus non-decidualized cells. Data represent the mean and SD summarized from three inde-
pendent experiments performed in duplicate. Statistical signiﬁcance of the differences above value for time point 0 h was determined by the Student’s
t-test (*P , 0.05). (C) IGF-IR and InsR protein levels measured by western blot. Immunoblotting of InsR and IGF-IR was performed on protein
extracts from untreated cells (2) and from cells treated with cAMP and MPA (þ). Whole cell lysates were extracted after 0, 8 h, 1, 3, 6 and 12
days of culture. Experiments were repeated three times with similar results.
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decidualized cells, with slightly faster electrophoretic mobility in com-
parison with the signal in non-decidualized cells. This could be due to
some degree of serine dephosphorylation since IRS-2 is a serine-rich
protein (White, 2002).
Phosphorylation status of IGF-IR, InsR, IRS-1
and IRS-2 in decidualized cells
The up-regulation of IGF-II, IGF-IR and InsR as well as of IRS-1 and -2
during the time course of decidualization is consistent with an auto-
crine/paracrine activation of the IGF signalling pathway. To verify
this hypothesis, we investigated the tyrosine phosphorylation levels
of the receptors and the adaptor proteins, after 6 days of decidualizing
treatment, in the absence or presence of exogenous IGFs. Proteins
were immunoprecipitated using speciﬁc antibodies for each receptor
and adaptor protein and were then probed with an anti-
phosphotyrosine antibody (aPY). Western blots using respective
antibodies conﬁrmed equal immunoprecipitation of proteins
between basal and IGF-stimulated conditions (data not shown). In
the absence of exogenous IGFs, IGF-IR and InsR were barely phos-
phorylated, since faint signals were detected only after a long exposure
in both untreated and treated ESCs, indicating a very low level of acti-
vation (data not shown). The addition of IGF-II at 500 ng/ml led to a
strong phosphorylation of IGF-IR and InsR in untreated cells but not in
treated cells, while LR3 IGF-I, an IGF-I analogue with a reduced afﬁnity
for IGFBPs, was able to activate the receptors in both untreated and
treated cells, suggesting that the presence of IGFBPs in decidualized
cells regulates the activation of receptors (Fig. 8A and B). The phos-
phorylation of IGF-IR and InsR by LR3 IGF-I was considerably more
pronounced in decidualized cells in comparison with untreated cells,
reﬂecting the higher level of functional protein expression in decidua-
lized cells (Fig. 5C). In parallel, phosphorylated IRS-1 was not detected
in the absence of added IGFs. As shown in Fig. 8C, IGF-II and LR3
IGF-I induced a similar level of IRS-1 phosphorylation in untreated
cells. However, in decidualized cells, IRS-1 phosphorylation was stron-
ger after LR3 IGF-I than after IGF-II treatment. In contrast, we
observed phosphorylated IRS-2 in decidualized cells without the
addition of IGFs and found that the phosphorylation increased at
the same level in the presence of either IGF-II or LR3 IGF-I. This
result indicates that IRS-2 could be activated despite high levels of
IGFBPs in treated cells (Fig. 8D). Furthermore, tyrosine phosphory-
lated IRS-2 migrated signiﬁcantly faster in decidualized than in non-
decidualized cell extracts, in agreement with the total IRS-2 immuno-
blot (Fig. 7C).
Discussion
Differentiation of ESCs constitutes a crucial event during the prep-
aration of the endometrium for blastocyst implantation and adequate
placental development. Decidualization plays two apparently paradox-
ical roles in implantation. On the one hand, the trophoblast–decidual
cell paracrine interactions are essential for placentation. On the other
hand, decidual cells limit the depth of implantation, preventing the
excessive trophoblast invasion observed in the absence of decidua,
such as in tubal pregnancy or in the placenta percreta associated
with scarring tissue (Gofﬁn et al., 2003b).
The present study demonstrates a strong modulation of IGF
system component expression in human ESCs undergoing decidualiza-
tion. Decidualizing treatment induced a signiﬁcant up-regulation of
IGF-II levels but not those of IGF-I. In the endometrium, IGF expression
is well-known to be controlled by steroid hormones during the
menstrual cycle. IGF-I has been described as a major ‘oestromedin’,
reaching maximal expression during the late proliferative phase. In
contrast, IGF-II is mainly expressed during the mid to late secretory
phase, under the inﬂuence of progesterone (Zhou et al., 1994; Gao
et al., 1999). Together, these observations argue for a role for IGF-II
rather than for IGF-I in the decidualization process.
The activity of IGFs is strongly modulated by IGFBPs, since they
control the availability of IGFs to receptors. IGFBP-1 is a major
protein produced by the decidualized endometrium and was used in
this study as a marker for ESC differentiation. Besides the high induc-
tion of IGFBP-1 levels, which could inhibit IGF action, we found
increased IGFBP-4 levels in decidualized cells. Interestingly, IGFBP-4
immunoblots of ESC CM showed pronounced proteolysis of the
Figure 6 Expression time course of InsR isoform mRNA during
decidualization. (A) InsR isoform mRNA levels measured by RT–
PCR in ESCs. Total RNA was extracted after 0, 8 h, 1, 3, 6, 12 days
of treatment from untreated cells (2) and from cells treated with
cAMP and MPA (þ). PCR experiments were performed with
primers ﬂanking exon 11 of InsR gene to distinguish isoform-A
(InsR-A; 600 bp) and -B (InsR-B; 636 bp). The ﬁgure presents a repre-
sentative RT–PCR experiment of three independent experiments. (B)
Fold induction of InsR isoform mRNA levels in ESC cultures. At each
time point, results are presented as the ratio of densitometric values
for InsR-A and InsR-B mRNA in decidualized versus non-decidualized
cells. Means and SD are calculated from three independent exper-
iments performed in duplicate. Statistical signiﬁcance of the differences
above value for time point 0 h was determined by the Student’s t-test
(*P , 0.05). (C) Relative abundance of InsR-A mRNA during decidua-
lization. Table presents the relative percentage of InsR-A mRNA in
untreated cells (ND) and in cells treated with cAMP and MPA (D).
Each value is the mean + SD of three separate experiments per-
formed in duplicate.
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binding protein in treated as well as in untreated cells. In vivo, IGFBP-4
is the second most abundant IGFBP produced by the human decidua,
after IGFBP-1 (Han and Carter, 2000). IGFBP-4 proteolysis generates
fragments with highly reduced afﬁnity for the IGFs and thus, represents
a major process in the regulation of IGF bioavailability. We conﬁrmed
by in vivo immunoneutralization experiments that PAPP-A was the pro-
tease responsible for IGFBP-4 degradation. PAPP-A has been
described as an IGF-II-dependent protease (Lawrence et al., 1999).
Qin et al. (2000) have established that physical interaction between
IGF-II and IGFBP-4 is required for the optimal proteolytic activity of
PAPP-A. In the study of Giudice et al., (2002), the proteolysis of
IGFBP-4 was examined by testing in-vitro the proteolytic activity of
ESC conditioned medium on recombinant [125I]IGFBP-4. In this
case, [125I]IGFBP-4 was only proteolyzed when exogenous IGF-II (5
nM 40 ng/ml) was added. We have to emphasize that we per-
formed our experiments in the absence of any exogenous IGF-II. It
is possible that in-vitro studies do not reﬂect the real proteolytic activity
of PAPP-A due to the presence of IGF-II in ESC medium. Moreover, it
has been suggested in several papers that PAPP-A activity is not strictly
IGF-dependent (Byun et al., 2001; Monget et al., 2003). Thus, we
propose that either some fraction of IGF-II produced by the cells is
able to activate PAPP-A and to induce proteolysis of endogenous
IGFBP-4 or that cleavage of IGFBP-4 is due to a basal,
IGF-independent activity of PAPP-A.
IGFBP-5 expression level was also affected by decidualizing
treatment. We observed a strong decrease in mRNA levels, which
became undetectable after 6 days of treatment. The mechanism of
IGFBP-5 gene repression in cAMP and progesterone-treated ESCs
remains to be elucidated. It is of particular interest to note that pro-
lactin is a strong inhibitor of IGFBP-5 expression in lactating mammary
glands (Tonner et al., 1997). Since decidualizing cells produce large
amounts of prolactin, this might explain our observation.
The actions of IGFs are mediated by IGF-IR and InsR. Both recep-
tors levels increased during the period of treatment, with a higher
induction observed for InsR. Furthermore, we report varying kinetics
between the two InsR isoforms mRNA. The InsR-A mRNA level
showed a stronger increase in decidualized cells than did the InsR-B
mRNA level and InsR-A became the major isoform after 3 days of
treatment. This is of particular interest since InsR-A presents a high
afﬁnity for IGF-II, in an order of magnitude comparable to IGF-IR.
Their interaction has been implicated in fetal growth and the physi-
ology of various cancers (Frasca et al., 1999). Thus, elevated levels
of both IGF-IR and InsR-A in decidualized cells provide a higher
binding capacity for locally available IGF-II.
Figure 7 Expression time course of IRS-1 and IRS-2 during decidualization. (A) IRS-1 and IRS-2 mRNA levels measured by RT–PCR in ESC cul-
tures. Total RNA was extracted from non-decidualized (ND) and decidualized (D) cells after 0, 8 h, 1, 3, 6 and 12 days of treatment. The presented
results are from a single representative experiment. The densitometric values obtained for IRS-1 and IRS-2 mRNA at each time point were referred to
the densitometric value at time 0 h considered as being equal to 1. (B) Fold induction of IRS-1 and IRS-2 mRNA levels. Table shows the ratio of
densitometric values at each time point in decidualized versus non-decidualized cells. Data represent the mean and SD summarized from three inde-
pendent experiments performed in duplicate. Statistical signiﬁcance of the differences above value for time point 0 h was determined by the Student’s
t-test (*P , 0.05). (C) IRS-1 and IRS-2 protein levels measured by western blot. Immunoblotting of IRS-1 and IRS-2 was performed on protein extracts
from untreated cells (2) and from cells treated with cAMP and MPA (þ). Whole cell lysates were extracted after 0, 8 h, 1, 3, 6 and 12 days of culture.
Experiments were repeated three times with similar results.
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We observed a higher expression of IRS-1 and IRS-2 in decidualized
cells. Changes in docking protein expression occurred early, as
observed in IGF-II, IGFBPs and receptors expression. This suggested
involvement of the network in the decidualization process. To test
this hypothesis, we investigated the phosphorylation status of recep-
tors and docking proteins during ESC differentiation. Our results
demonstrated that IGF-II produced by decidualized cells did not give
rise to a sustained autophosphorylation of IGF-IR and InsR. We also
tested the possibility that the two receptors could be activated in
decidualized cells by a paracrine mechanism, since large amounts of
IGF-II are produced by placental trophoblasts at the feto–maternal
interface during placentation. The addition of exogenous IGF-II failed
to phosphorylate IGF-IR and InsR in decidualized cells. This was prob-
ably due to the presence of IGFBPs, since treatment with LR3 IGF-I,
presenting a reduced afﬁnity for IGFBPs, induced high phosphorylation
levels in both receptors. It is important to mention that immunopre-
cipitation with either IGF-IR or InsR-speciﬁc antibody can also lead
to the recovery of hybrid IGF-I/Ins receptors. It is very likely that
hybrid receptors are present in ESCs since they have been reported
in most cell types expressing signiﬁcant levels of both IGF-IR and
InsR (Bailyes et al., 1997; Federici et al., 1997). So, the phosphotyro-
sine signals detected in immunoprecipitated extracts could correspond
to the combination of phosphorylated homodimers and hybrid recep-
tors. However, the exact contribution of hybrid receptors in the
biological action of the IGFs is unclear. And understanding their
exact role is rendered more difﬁcult by the fact that InsR exists in
two isoforms and that the relative abundance of the isoforms can
lead to different effects in terms of ligand binding and signal transduc-
tion (Pandini et al., 2002). Whether a higher proportion of hybrid
receptors containing InsR-A than hybrid receptors containing InsR-B
is present in decidualized ESCs remains to be elucidated, as does
the way in which these hybrid receptors contribute to IGF signalling
activity.
We observed a distinct pattern of IRS-1 and IRS-2 phosphorylation
in basal and IGF-stimulated conditions. The IRS-1 pattern of activation
was similar to that of the receptors. Indeed, in decidualized cells, we
could detect a sustained IRS-1 tyrosine phosphorylation only after the
addition of LR3 IGF-I to the culture medium. In contrast, IRS-2 was
slightly phosphorylated in decidualized cells without the addition of
IGFs and phosphorylation was signiﬁcantly increased by the addition
of IGF-II or LR3 IGF-I. It has been recently reported that a speciﬁc
and sustained activation of IRS-2 was induced by IGFs through InsR
in spite of low phosphorylation of the receptor (Denley et al.,
2007). Some studies had already suggested that high levels of InsR
and IGF-IR phosphorylation might not be required for all biological
actions of the receptors (Sbraccia et al., 1990; Rafaeloff et al., 1991;
Blakesley et al., 1995; Stannard et al., 1995). Despite structural and
functional similarities, IRS-1 and IRS-2 differ in some respects as
proven by the study of targeted disruptions of the genes coding for
the two adaptors (Withers et al., 1999). Both proteins contain a
speciﬁc set of multiple tyrosine phosphorylation sites at their C-
terminus, allowing the recruitment of various SH2 domain-containing
signalling molecules (White, 2002). In addition, the two IRS proteins
might differ in their mode of interaction with InsR and IGF-IR (He
et al., 1996; Sawka-Verhelle et al., 1996), suggesting distinct mechan-
isms of regulation. It would be interesting to ﬁnd out which signalling
proteins are recruited by IRS-2 activation in decidualized cells and
which receptor is responsible for the adaptor activation. Furthermore,
we observed a faster migrating IRS-2 in decidualized cells, which could
be due to a lower serine phosphorylation level. Several studies have
suggested that high serine/threonine phosphorylation of IRS is inhibi-
tory for insulin signalling, since it has been shown to reduce tyrosine
phosphorylation (Tanti et al., 1994; Eldar-Finkelman and Krebs,
1997; Sharﬁ and Eldar-Finkelman, 2008). Therefore, speciﬁc regulation
of IRS-2 phosphorylation could occur in decidualized cells, favouring
signalling activation.
In conclusion, our overall results suggest that the IGF signalling
pathway is only weakly activated by autocrine IGF-II during in-vitro
differentiation of ESCs. But the profound changes in the expression
of its components indicate that the signalling pathway is ready to be
activated. We propose that in vivo, once placentation occurs and a
high level of IGF-II is present at the feto–maternal interface, the IGF
signalling pathway could be fully activated to act in the maintenance
and in the growth of decidualized endometrial cells, mediated
mostly by IRS-2 activation. It has been shown that IGFs can inﬂuence
the production of IGFBP-1 and PRL and stimulate the growth of ESCs
(Frost et al., 1993; Irwin et al., 1993, 1994; Tang et al., 1994; Tseng
and Mazella, 2002). High level expression of endometrial IGFBPs
and trophoblatic IGF-II and IGFBP proteases could thus allow a loca-
lized and a strongly controlled action of IGF-II on the trophicity of the
basilar decidua during pregnancy.
Figure 8 Phosphorylation status of IGF-IR, InsR, IRS-1 and IRS-2.
Conﬂuent ESCs were cultured in DMEM/F12 2% charcoal-treated FBS
with 0.5 mM 8-br-cAMP and 1 mM MPA (þ) or ethanol (2) for 6
days. IGF-II or Long R3 IGF-I (500 ng/ml) was added, or not, 15 min
before protein extraction. Protein samples were immunoprecipitated
with either anti-IGF-IR antibody (A), anti-InsR antibody (B), anti-IRS-1
antibody (C) or anti-IRS-2 antibody (D) in parallel with IgG control
and then subjected to western blot with anti-phosphotyrosine 4G10
(PY) antibody. Experiments were repeated three times with similar
results. IP, immunoprecipitation; IB, immunoblot.
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